Non-invasive transient elastography for the prediction of liver toxicity following hematopoietic SCT.

Auberger, J; Graziadei, I; Clausen, J; Vogel, W; Nachbaur, D; Bone Marrow Transplant. 2013; 48(1): 159-160.

Mimicking the microenvironment in chronic lymphocytic leukaemia – where does the journey go?

Asslaber, D; Grössinger, EM; Girbl, T; Hofbauer, SW; Egle, A; Weiss, L; Greil, R; Hartmann, TN; Br J Haematol. 2013; 160(5):711-714

Rituximab plus subcutaneous cladribine in patients with extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue: a phase II study by the Arbeitsgemeinschaft Medikamentose Tumortherapie.

Troch, M; Kiesewetter, B; Willenbacher, W; Willenbacher, E; Zebisch, A; Linkesch, W; Fridrik, M; Müllauer, L; Greil, R; Raderer, M; Haematologica. 2013; 98(2): 264-268.

CD40-mediated activation of chronic lymphocytic leukemia cells promotes their CD44-dependent adhesion to hyaluronan and restricts CCL21-induced motility.

Girbl, T; Hinterseer, E; Grössinger, EM; Asslaber, D; Oberascher, K; Weiss, L; Hauser-Kronberger, C; Neureiter, D; Kerschbaum, H; Naor, D; Alon, R; Greil, R; Hartmann, TN; Cancer Res. 2013; 73(2): 561-570.

Protein kinase c-β-dependent activation of NF-κB in stromal cells is indispensable for the survival of chronic lymphocytic leukemia B cells in vivo.

Lutzny, G; Kocher, T; Schmidt-Supprian, M; Rudelius, M; Klein-Hitpass, L; Finch, AJ; Dürig, J; Wagner, M; Haferlach, C; Kohlmann, A; Schnittger, S; Seifert, M; Wanninger, S; Zaborsky, N; Oostendorp, R; Ruland, J; Leitges, M; Kuhnt, T; Schäfer, Y; Lampl, B; Peschel, C; Egle, A; Ringshausen, I; Cancer Cell. 2013; 23(1):77-92

CYP2D6 Metabolism and Patient Outcome in the Austrian Breast and Colorectal Cancer Study Group Trial (ABCSG) 8.

Goetz, MP; Suman, VJ; Hoskin, TL; Gnant, M; Filipits, M; Safgren, SL; Kuffel, M; Jakesz, R; Rudas, M; Greil, R; Dietze, O; Lang, A; Offner, F; Reynolds, CA; Weinshilboum, RM; Ames, MM; Ingle, JN; Clin Cancer Res. 2013; 19(2): 500-507.

Systemic effect of catumaxomab in a patient with metastasized colorectal cancer: a case report.

Bezan, A; Hohla, F; Meissnitzer, T; Greil, R; BMC Cancer. 2013; 13(1): 618

Targeting triple-negative breast cancer through the somatostatin receptor with the new cytotoxic somatostatin analogue AN-162 [AEZS-124].

Seitz, S; Buchholz, S; Schally, AV; Jayakumar, AR; Weber, F; Papadia, A; Rick, FG; Szalontay, L; Treszl, A; Köster, F; Ortmann, O; Hohla, F; Anticancer Drugs. 2013; 24(2):150-157

The occurrence of dental caries is associated with atherosclerosis.

Glodny, B; Nasseri, P; Crismani, A; Schoenherr, E; Luger, AK; Bertl, K; Petersen, J Clinics (Sao Paulo). 2013; 68(7):946-953

p53 efficiently suppresses tumor development in the complete absence of its cell-cycle inhibitory and proapoptotic effectors p21, Puma, and Noxa.

Valente, LJ; Gray, DH; Michalak, EM; Pinon-Hofbauer, J; Egle, A; Scott, CL; Janic, A; Strasser, A; Cell Rep. 2013; 3(5):1339-1345